Abstract
Background
Cancer cells develop mechanisms to evade immune cells and achieve progression. Aberrant B7-H1 and B7-1 expressions may help pancreatic carcinoma (PC) cells escape immune attack; these molecules can be considered as prognostic markers for patients with PC who have undergone radical resection.
Methods
We recruited 81 patients who had undergone radical surgical resection for PC between 1999 and 2007. To investigate the prognostic factors, we evaluated the B7-H1 and B7-1 protein expressions in the tissue specimens of these 81 patients by immunohistochemistry and analyzed the clinical and pathological features of these specimens.
Results
B7-H1 was expressed mainly in pancreatic islets, and no B7-1 expression was detected in normal pancreatic tissues. B7-H1 and B7-1 expressions were higher in pancreatic carcinoma tissues than in normal pancreatic tissues (P < 0.05). B7-H1 and B7-1 significantly correlated with the pathological grade and tumor-node-metastasis (TNM) stage, respectively (P < 0.05). Furthermore, B7-1-negative or B7-H1-positive statuses were prognostic indicators of poor disease-specific survival (P < 0.05), but only combined B7-1/B7-H1 expression retained the prognostic potential after adjusting by Cox proportional hazards regression models (P < 0.05).
Conclusions
Both B7-H1 and B7-1 are expressed in PC; these molecules are important markers for PC progression. Furthermore, combined B7-1/B7-H1 expression can serve as an independent prognostic marker for PC.
Similar content being viewed by others
References
Ichikawa M, Chen L (2005) Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms. Front Biosci 10:2856–2860
Geng L, Huang D, Liu J et al (2008) B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression. J Cancer Res Clin Oncol 134:1021–1027
Choi IH, Zhu G, Sica GL et al (2003) Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 171:4650–4654
Krambeck AE, Dong H, Thompson RH et al (2007) Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clin Cancer Res 13:1749–1756
Ghebeh H, Tulbah A, Mohammed S et al (2007) Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells. Int J Cancer 121:751–758
Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793–800
Strome SE, Dong H, Tamura H et al (2003) B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 63:6501–6505
Chen L (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4:336–347
Curiel TJ, Wei S, Dong H et al (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9:562–567
Hirano F, Kaneko K, Tamura H et al (2005) Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 65:1089–1096
Lukens JR, Cruise MW, Lassen MG et al (2008) Blockade of PD-1/B7-H1 interaction restores effector CD8+ t cell responses in a hepatitis C virus core murine model. J Immunol 180:4875–4884
Blank C, Kuball J, Voelkl S et al (2006) Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer 119:317–327
Brown JA, Dorfman DM, Ma FR et al (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170:1257–1266
Hicks C, Keoshkerian E, Gaudry L et al (2001) CD80 (B7-1) expression on human acute myeloid leukemic cells cultured with GM-CSF, IL-3 and IL-6. Cancer Immunol Immunother 50:173–180
Tirapu I, Huarte E, Guiducci C et al (2006) Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Res 66:2442–2450
Esposito I, Friess H, Buchler MW (2001) Molecular mechanisms in chronic pancreatitis. Zentralbl Chir 126:867–872
Yadav D, Fine C, Azuma M et al (2007) B7-1 mediated costimulation regulates pancreatic autoimmunity. Mol Immunol 44:2616–2624
Putzer BM, Rodicker F, Hitt MM et al (2002) Improved treatment of pancreatic cancer by IL-12 and B7.1 costimulation: antitumor efficacy and immunoregulation in a nonimmunogenic tumor model. Mol Ther 5:405–412
Antonia SJ, Munoz-Antonia T, Soldevila G et al (1995) B7-1 expression by a non-antigen presenting cell-derived tumor. Cancer Res 55:2253–2256
Nagakawa T, Kayahara M, Ueno K et al (1992) A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer 69:930–935
Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263–274
Dunn GP, Koebel CM, Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836–848
Azuma T, Yao S, Zhu G et al (2008) B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 111:3635–3643
DiPaola RS, Plante M, Kaufman H et al (2006) A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer. J Transl Med 4:1
Chen M, Si H, Si L et al. (2000) Immunocytochemistry study of b7.1 in six tumor cell lines. Teratog Carcinog Mutagen 219–220
Loos M, Giese NA, Kleeff J et al (2008) Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer. Cancer Lett 268:98–109
Marco GS, Colucci JA, Fernandes FB et al (2008) Diabetes induces changes of catecholamines in primary mesangial cells. Int J Biochem Cell Biol 40:747–754
Tentolouris N, Argyrakopoulou G, Katsilambros N (2008) Perturbed autonomic nervous system function in metabolic syndrome. Neuromolecular Med 10:169–178
Hong SP, Jeong MG, Lim DY (2007) Effect of anabasine on catecholamine secretion from the perfused rat adrenal medulla. J Cardiol 50:351–362
Straub RH, Harle P (2005) Stress, hormones, and neuronal signals in the pathophysiology of rheumatoid arthritis. The negative impact on chronic inflammation. Med Klin (Munich) 100:794–803
Reiche EM, Morimoto HK, Nunes SM (2005) Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry 17:515–527
Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5:617–625
Acknowledgements
We thank Mr. Paul Howell (research assistant from Mitchell Cancer institute) for help revising this manuscript, and Ms. Paul Huiling Gong and Min Wang (pathologists of pathology department, First Affiliated Hospital of Xi’an Jiaotong University) for help reviewing slides and images analyses.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Scientific Fund of Shaanxi Province (2008k09-04).
Rights and permissions
About this article
Cite this article
Wang, L., Ma, Q., Chen, X. et al. Clinical Significance of B7-H1 and B7-1 Expressions in Pancreatic Carcinoma. World J Surg 34, 1059–1065 (2010). https://doi.org/10.1007/s00268-010-0448-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-010-0448-x